SCHEMBL22737262

SCHEMBL22737262

N#Cc1cccc(C#N)c1-c1ccc2c(c1)c1c(-c3c(C#N)cccc3C#N)cccc1n2-c1ccc(-c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPK1 P28482 2/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SSTR2 P30874 1/20 0.35
GABRG2 P18507 2/20 0.34
GABRB3 P28472 2/20 0.34
GABRA5 P31644 2/20 0.34
GABRA3 P34903 2/20 0.34
GABRA1 P14867 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAOA P21397 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22737388 0.95 KDM4E (0.36) NR3C1ALDH1A1MAPK1SSTR2GABRG2
SCHEMBL22737259 0.95 KDM4E (0.38) NR3C1ALDH1A1MAPK1LMNAHPGD
SCHEMBL22737082 0.93 GABRG2 (0.35) NR3C1ALDH1A1MAPK1LMNAHPGD
SCHEMBL22737258 0.93 GABRG2 (0.37) NR3C1ALDH1A1MAPK1LMNAHPGD
SCHEMBL22737017 0.92 KDM4E (0.40) NR3C1ALDH1A1MAPK1LMNAHPGD
SCHEMBL22737405 0.92 GABRG2 (0.37) NR3C1ALDH1A1MAPK1LMNAHPGD
SCHEMBL22737663 0.92 SMN1; SMN2 (0.37) NR3C1ALDH1A1MAPK1LMNAHPGD
SCHEMBL22737075 0.92 KDM4E (0.37) NR3C1ALDH1A1MAPK1LMNAHPGD
SCHEMBL22737463 0.91 KDM4E (0.39) ALDH1A1MAPK1LMNAHPGDSMN1; SMN2
SCHEMBL22737278 0.91 GABRG2 (0.40) NR3C1ALDH1A1MAPK1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200377490-A1 CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME, AND ELECTRONIC DEVICE INCLUDING ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377490-A1 CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME, AND ELECTRONIC DEVICE INCLUDING ORGANIC LIGHT-EMITTING DEVICE CCNE2, CRY2, PER2 NR3C1 1779/4885ALDH1A1 520/4885MAPK1 2780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.